01 7Copaxone
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 1,512
2018 Revenue in Millions : 2,366
Growth (%) : -36
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 1,337
2019 Revenue in Millions : 1,512
Growth (%) : -12
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 1,005
2020 Revenue in Millions : 1,337
Growth (%) : -25
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 691
2021 Revenue in Millions : 1,005
Growth (%) : -31
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 590
2022 Revenue in Millions : 691
Growth (%) : -15
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 3,801
2016 Revenue in Millions : 4,223
Growth (%) : -10
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 2,366
2017 Revenue in Millions : 3,802
Growth (%) : -38%
LOOKING FOR A SUPPLIER?